Skip to main content

Table 1 Basic patient demographics

From: Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma

  Discovery stage Validation stage
NPC Control NPC Control
Number 7 7 129 100
Gender
 Male 5 5 100 41
 Female 2 2 29 59
Mean age ± SD (years) 59 ± 12 59 ± 10 51 ± 12 51 ± 10
Age range (years) 38–76 40–74 19–76 24–79
T stage
 T1 0   19  
 T2 2   46  
 T3 3   39  
 T4 2   25  
N stage
 N0 1   17  
 N1 1   50  
 N2 5   55  
 N3 0   7  
M stage
 M0 6   122  
 M1 1   7  
Overall stage
 I 0   4  
 II 0   36  
 III 4   55  
 IV 3   34  
Back to article page

Clinical Proteomics

ISSN: 1559-0275